Photo by Nick Sarvari on Unsplash
Macy’s Might Be Bought Out for $5.8 Billion
December 11, 2023
Investors of the iconic American retailer, Macy’s, have been gifted a seasonal surprise: Macy’s has received a major buyout proposition. Arkhouse Management, a renowned real estate investor, and Brigade Capital Management, a proficient asset manager, put forth a substantial $5.8 billion offer, according to a source familiar with the matter.
With a proposal submission date of Dec. 1, the offer aims to secure Macy’s at roughly $21 per share. Macy’s board of directors — a commendable group of retail industry veterans, including former Home Depot CEO, Frank Blake — are currently deliberating over this unexpected offer. With a 32.4% premium on Macy’s closing price as of Nov. 30, the proposed buyout price has garnered attention. The retail giant’s shares experienced a positive surge, rising by 16% to $20.23 in early Monday trading following the announcement.
The company’s board faces a challenging decision. The proposed value per share is significantly lower than Macy’s all-time high stock price of $70.99 recorded on June 15, 2015. In contrast, the shares were exchanged at $17.39 at close last Friday, as per Yahoo Finance data.
Moreover, the evaluation of the company’s real estate assets cannot be overlooked. Back in 2022, investment bank Cowen evaluated Macy’s real estate holdings to be worth between $6 billion and $8 billion. The prized real estate portfolio, which is spotlighted by the emblematic Herald Square location in New York City, has been valued between $3 billion and $4 billion over the past decade by various money managers.
In addition to evaluating the financial implications of this proposed buyout, Macy’s must consider the potential disruptions to its operations. Amid the holiday shopping frenzy, a buyout process could introduce possible turmoil. Furthermore, the company’s leadership will undergo a transition in February 2024 when Tony Spring is set to replace the retiring CEO, Jeff Gennette.
All in all, the unexpected $5.8 billion buyout offer presents a complex conundrum to Macy’s. The decision on whether to accept the offer or not will undoubtedly be a critical milestone in the company’s storied history.
Recent News
Massive Data Breach Hits Ticketmaster, Affecting 560 Million Customers
Ticketmaster has fallen victim to a significant cyber-attack, potentially compromising the data of up to 560 million customers. The breach was confirmed by Ticketmaster’s parent company, Live Nation, which revealed that a notorious hacking group, ShinyHunters, is behind the attack. The hackers are demanding a ransom of approximately £400,000 to prevent the data from being sold on the dark web.
Toyota Recalls 100,000+ Tundra and Lexus LX SUVs Over Engine Debris Issue
Toyota has announced a recall for over 100,000 Tundra pickups and Lexus LX SUVs in North America due to potential engine issues caused by machining debris. This recall affects certain 2022-2023 models of the Tundra and LX, which are equipped with the new V6 twin-turbo engine. The V6 twin-turbo engine has faced considerable scrutiny regarding its reliability, especially when compared to the previous naturally aspirated V8 engines.
Wordle and Worldle Battle Over Names
A legal dispute has erupted between the wildly popular word game Wordle and the lesser-known geography game Worldle, centering on the similarity of their names. Wordle, which was developed by Josh Wardle in 2021 and later acquired by the New York Times in 2022 for a substantial sum, has gained immense popularity. In this game, players have six attempts to guess a five-letter word.
FDA Issues Recall for Crecelac Goat Milk Infant Formula
The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding Crecelac Goat Milk Infant Formula and other infant formula products imported and distributed by Dairy Manufacturers Inc. The alert highlights Cronobacter contamination concerns with Crecelac Infant Powdered Goat Milk Infant Formula. Although Dairy Manufacturers Inc. initiated a recall on May 24, 2024, due to non-compliance with FDA regulations, new findings of Cronobacter contamination have prompted further action.